Haemonetics Corporation
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionQube Research & Technologies Ltd
Latest Disclosed Ownership430,152 shares
Latest Disclosed Value $ 24,243,367
Qube Research & Technologies Ltd reports 216.79% increase in ownership of HAE / Haemonetics Corporation

On May 15, 2026 - Qube Research & Technologies Ltd filed a 13F-HR form disclosing ownership of 430,152 shares of Haemonetics Corporation (US:HAE) valued at $24,243,367 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 135,786 shares of Haemonetics Corporation. This represents a change in shares of 216.79% during the quarter. The current value of the position is $28,338,414 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F HAEMONETICS CORP MASS COM 405024100 430,152 294,366 216.79 24,243 122.76 0.0270
2026-02-17 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 135,786 -134,578 -49.78 10,883 -17.41 0.0111
2025-11-14 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 270,364 270,364 13,178 0.0136
2025-08-14 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 0 -34,009 -100.00 0 -100.00
2025-05-15 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 34,009 -7,866 -18.78 2,161 -33.89 0.0025
2025-02-14 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 41,875 41,875 3,270 0.0043
2024-11-14 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 0 -43,122 -100.00 0 -100.00
2024-08-14 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 43,122 43,122 3,567 0.0056
2024-05-14 2024-03-31 13F HAEMONETICS CORP MASS COM 405024100 0 -42,645 -100.00 0 -100.00
2024-02-13 2023-12-31 13F HAEMONETICS CORP MASS COM 405024100 42,645 42,589 76,051.79 3,647 72,820.00 0.0071
2023-11-13 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 56 -13,253 -99.58 5 -99.56 0.0000
2023-08-14 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 13,309 -2,407 -15.32 1,133 -12.85 0.0041
2023-05-15 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 15,716 -23,897 -60.33 1,300 -58.27 0.0056
2023-02-14 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 39,613 15,278 62.78 3,116 72.86 0.0167
2022-11-14 2022-09-30 13F HAEMONETICS CORP MASS COM 405024100 24,335 665 2.81 1,802 16.79 0.0107
2022-08-15 2022-06-30 13F HAEMONETICS CORP MASS COM 405024100 23,670 23,670 1,543 0.0114
2021-08-13 2021-06-30 13F HAEMONETICS CORP MASS COM 405024100 0 -25,827 -100.00 0 -100.00
2021-05-14 2021-03-31 13F HAEMONETICS CORP MASS COM 405024100 25,827 25,827 2,867 0.0455
2020-11-12 2020-09-30 13F HAEMONETICS COM 405024100 0 -35,224 -100.00 0 -100.00
2020-08-14 2020-06-30 13F HAEMONETICS COM 405024100 35,224 35,224 3,155 0.0463
2020-05-15 2020-03-31 13F HAEMONETICS COM 405024100 0 -1,954 -100.00 0 -100.00
2020-02-13 2019-12-31 13F HAEMONETICS COM 405024100 1,954 1,954 225 0.0071
2019-11-13 2019-09-30 13F HAEMONETICS COM 405024100 0 -2,135 -100.00 0 -100.00
2019-08-02 2019-06-30 13F HAEMONETICS COM 405024100 2,135 2,135 257 0.0612
2019-02-14 2018-12-31 13F HAEMONETICS COM 405024100 0 -1,735 -100.00 0 -100.00
2018-11-14 2018-09-30 13F HAEMONETICS COM 405024100 1,735 1,294 293.42 199 397.50 0.0265
2018-08-15 2018-06-30 13F/A-1 HAEMONETICS COM 405024100 441 441 40 0.0252
2018-08-14 2018-06-30 13F HAEMONETICS COM 405024100 441 40 0.0252
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.